Literature DB >> 30012290

The Basic Science of Dupuytren Disease.

Andrew Y Zhang1, Jennifer S Kargel2.   

Abstract

Dupuytren disease is a fibroproliferative condition affecting the hands of millions of patients worldwide. The hypothesis of pathogenesis involves genetic factors and internal factors. Recent genome-wide association studies have provided much needed evidence for the long-held belief of a strong genetic component to the pathogenesis of Dupuytren disease. Specifically, abnormal activation of the Wnt signaling pathway plays an important role. Regarding internal factors, microvascular angiopathy and ischemia have been shown to lead to activation of transforming growth factor-β1 and proliferation of myofibroblasts.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dupuytren disease; Genetics; Growth factors; Myofibroblast; Pathogenesis; Wnt pathway

Mesh:

Substances:

Year:  2018        PMID: 30012290     DOI: 10.1016/j.hcl.2018.03.001

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  3 in total

1.  The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.

Authors:  Gediminas Samulenas; Ruta Insodaite; Edita Kunceviciene; Roberta Poceviciute; Lorena Masionyte; Urte Zitkeviciute; Loreta Pilipaityte; Alina Smalinskiene
Journal:  Genes (Basel)       Date:  2022-04-23       Impact factor: 4.141

2.  Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture.

Authors:  Gediminas Samulėnas; Alina Smalinskienė; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

3.  Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (DupuyShock).

Authors:  Karsten Knobloch; Marie Hellweg; Heiko Sorg; Tomas Nedelka
Journal:  Lasers Med Sci       Date:  2021-01-23       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.